论文信息 - First in patient study of anti-GM-CSF monoclonal antibody (MOR103) in active rheumatoid arthritis: Results of a phase 1b/2a randomized, double-blind, placebo-controlled trial - 字舞流文

First in patient study of anti-GM-CSF monoclonal antibody (MOR103) in active rheumatoid arthritis: Results of a phase 1b/2a randomized, double-blind, placebo-controlled trial

P. Tak | A. Schottelius | T. Huizinga | M. Østergaard | H. Burkhardt | J. Rech | P. Wiland | A. Rubbert-Roth | B. Ejbjerg | F. Behrens | M. Korkosz | R. Korolkiewicz | I. Zupanets | J. Geiseler | R. Stoilov | J. Fresenius | S. Vladeva | V. Y. Berenfus | D. Rekalov